BioSpace News Archive

PhoreMost Ltd., a leading UK biopharmaceutical company unlocking the next generation of drug targets, announced the introduction of GlueSEEKER™.

Engitix Ltd announces the appointment of Matthew Edwards, Ph.D., as Senior Vice President of Discovery Sciences, and Emma Huang, Ph.D., as Vice President of Data Sciences.

HighField Biopharmaceuticals announced that its abstract of preclinical data evaluating an mRNA-based GLP-1R agonist in diabetic monkeys has been accepted for a poster presentation at the American Diabetes Association 84th Scientific Sessions June 21-24, 2024, in Orlando, FL.

Biodesix, Inc., a leading diagnostic solutions company with a focus in lung disease, announced that new data will be presented at the 2024 American Thoracic Society International Conference in San Diego, California.

The Department of Health – Abu Dhabi, the regulator of the healthcare sector in the Emirate, signed a Memorandum of Understanding with Roche Pharmaceuticals Middle East during Abu Dhabi Global Healthcare Week.

ProKidney Corp. will host a virtual KOL event on Tuesday, May 28, 2024 at 8:00 AM ET, featuring Steven G. Coca, DO, MS and Arnold L. Silva, MD, PhD who will discuss the unmet medical need and current treatment landscape for patients with moderate to severe CKD caused by diabetes as well as the importance of preserving kidney function in this patient population.

Avadel Pharmaceuticals plc, a biopharmaceutical company focused on transforming medicines to transform lives, announced the appointment of Naseem Amin, M.D. to its board of directors, effective May 17, 2024.

ASLAN Pharmaceuticals announced the late-breaking poster presentation of translational data from head-to-head studies of eblasakimab and dupilumab in human healthy and COPD-derived lung tissue models at the American Thoracic Society International Conference 2024 in San Diego, California.

Clario, a healthcare research and technology company that delivers leading endpoint solutions for clinical trials, is pleased to announce a strategic partnership with Emsere, a trusted medical equipment supplier for clinical trials.

Atom Bioscience, a clinical stage biotechnology company developing new treatments for metabolic and inflammatory diseases, such as gout, is calling for increased understanding of the dangers of chronic gout to help mark Gout Awareness Day, May 22, 2024.